RAC 2.86% $1.44 race oncology ltd

Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene, page-165

  1. 1,244 Posts.
    lightbulb Created with Sketch. 2461
    not telling you much you don’t know but my assessment:

    Covid hype calmed down and everyone went back to work instead of playing the ASX casino with govt hand outs & super withdrawals.

    Then our then deal man the chairman sold $1m worth highlighting nothing PS or exciting on the horizon, Cardio/FTO pivot extended timelines and confused the market on a path to market. Then the biotech sector tanked taking everything with it that wasn’t revenue producing.

    More recently tax loss selling & uncertainty a triune management changes or strategy IMO.

    The good news, nothing went wrong, nothing fundamentally bad. I believe we have bottomed, consolidated and flushed out panicked retail, and pretty much all of the above has been addressed or is about to be. It’s only level or up from here
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.44
Change
0.040(2.86%)
Mkt cap ! $245.3M
Open High Low Value Volume
$1.45 $1.49 $1.41 $101.7K 69.88K

Buyers (Bids)

No. Vol. Price($)
1 9216 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.47 7767 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.